Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gabriel

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2009
Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphyDaniel Putzer, Michael Gabriel, Benjamin Henninger, et al.
Reproductive Medicine and Biology|March 26, 2025
Combined targeting of TCF7L1/2, PTEN, CDK6, and BCCIP by microRNA miR-29c-3p is associated with reduced invasion and proliferation of endometriotic cellsTeresa Helene Wentges, Heba M El-Shorafa, Janine Beckmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 1, 2011
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidineAlexander Kroiss, Daniel Putzer, Christian Uprimny, et al.
Diagnostics (Basel, Switzerland)|January 28, 2026
MRI, PET/CT and PET/MRI Fusion in the Assessment of Lymph Node Metastases in Head and Neck CancerNikolaus Poier-Fabian, Christian Asel, Hanna Cristurean, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2012
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarificationAlexander Kroiss, Daniel Putzer, Christian Uprimny, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2012
Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotideDaniel Putzer, Alexander Kroiss, Dietmar Waitz, et al.
International Journal of Molecular Sciences|March 10, 2022
Impact of Musashi-1 and Musashi-2 Double Knockdown on Notch Signaling and the Pathogenesis of EndometriosisTheresa Strauß, Burkhard Greve, Michael Gabriel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2010
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATEIrene Virgolini, Valentina Ambrosini, Jamshed B Bomanji, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 7, 2021
Association of adipocytokines serum levels with left atrial thrombus formation in atrial fibrillation patients on oral anticoagulation (Alert) - A cross-sectional studyHermann Blessberger, Patrick Mueller, Hisaki Makimoto, et al.
Clinical Nuclear Medicine|December 26, 2015
18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With TuberculosisIngrid Stelzmueller, Helmut Huber, Rainer Wunn, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2009
Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphyDaniel Putzer, Michael Gabriel, Benjamin Henninger, et al.
Reproductive Medicine and Biology|March 26, 2025
Combined targeting of TCF7L1/2, PTEN, CDK6, and BCCIP by microRNA miR-29c-3p is associated with reduced invasion and proliferation of endometriotic cellsTeresa Helene Wentges, Heba M El-Shorafa, Janine Beckmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 1, 2011
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidineAlexander Kroiss, Daniel Putzer, Christian Uprimny, et al.
Diagnostics (Basel, Switzerland)|January 28, 2026
MRI, PET/CT and PET/MRI Fusion in the Assessment of Lymph Node Metastases in Head and Neck CancerNikolaus Poier-Fabian, Christian Asel, Hanna Cristurean, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2012
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarificationAlexander Kroiss, Daniel Putzer, Christian Uprimny, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2012
Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotideDaniel Putzer, Alexander Kroiss, Dietmar Waitz, et al.
International Journal of Molecular Sciences|March 10, 2022
Impact of Musashi-1 and Musashi-2 Double Knockdown on Notch Signaling and the Pathogenesis of EndometriosisTheresa Strauß, Burkhard Greve, Michael Gabriel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2010
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATEIrene Virgolini, Valentina Ambrosini, Jamshed B Bomanji, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 7, 2021
Association of adipocytokines serum levels with left atrial thrombus formation in atrial fibrillation patients on oral anticoagulation (Alert) - A cross-sectional studyHermann Blessberger, Patrick Mueller, Hisaki Makimoto, et al.
Clinical Nuclear Medicine|December 26, 2015
18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With TuberculosisIngrid Stelzmueller, Helmut Huber, Rainer Wunn, et al.
Pageof 12